Somatically acquired gains or losses of DNA segments, known as CNAs, are an important class of genetic lesions that contribute to cancer initiation, progression and relapse 1 . WGS of tumor samples 2 should greatly improve the ability to detect somatic (tumor-acquired) CNAs relative to what is possible with methods such as array comparative genome hybridization and SNP array, because it avoids signal saturation in high-level amplification, has a greater capability for detecting focal events that may span <1 kilobase (kb) and can define CNA boundaries at base-pair resolution. However, despite the availability of many analysis algorithms (for example, SegSeq 3 , CNV-seq 4 , FREEC 5 , CNVnator 6 and BIC-seq 7 ), accurate identification of CNAs remains problematic. Although large CNAs can be reliably identified, bona fide independent assay, were expected to be highly accurate on the basis of prior studies 1 , and in many cases were validated using orthogonal technology. To summarize the accuracy of each CNA analysis method, we calculated the F 1 score (Online Methods) between WGS and SNP array and the number of WGS CNA segments that were uncorroborated by SNP array. The results ( Fig. 2b and Supplementary Table 3) showed that among all paired CNA methods, CONSERTING had the greatest consistency with SNP array, with a median F 1 score of 0.99 and a median of 8 (range: 2-26) uncorroborated CNA segments per genome. BIC-seq ranked second with a median F 1 score of 0.90, but with a much higher number of uncorroborated CNA segments per tumor (median, 294; range, 89-4,521). Analysis of receiver operating characteristic curves for the T-ALL samples ( Supplementary Fig. 4 ) also suggested that CONSERTING achieved near-optimal CNA-calling performance.
In the analysis of WGS data on adult glioblastoma multiforme from The Cancer Genome Atlas (TCGA-GBM), CONSERTING also showed greater consistency with SNP array compared to BIC-seq: median F 1 scores were 0.96 and 0.90 for CONSERTING and BIC-seq, respectively (Fig. 2c, Supplementary Fig. 3 , Supplementary Table 4 and Supplementary Data 1). The median number of uncorroborated CNA segments per genome was 58 with CONSERTING, which is significantly fewer (P = 3.0 × 10 −6 by Wilcoxon signed-rank test) than the 778 observed with BIC-seq. The melanoma cell line COLO-829 analyzed in our dilution experiment had approximately 40% tumor purity. Although the global CNA profile generated from both CONSERTING and BIC-seq matched well with the published SKY mapping result for the undiluted COLO-829 (ref. 14) (Fig. 2d) , there was a tenfold difference in the number of CNA segments predicted by CONSERTING and by BIC-seq. Whereas 76% of the 104 CNA segment boundaries predicted by CONSERTING matched validated SVs reported in the literature 14, 15 (Supplementary  Table 5 ), only 4.4% of the 1,004 CNAs generated by BIC-seq matched the validated SVs (Online Methods).
Chromothripsis has recently been recognized as a mechanism that can generate multiple CNAs through a massive, single-step genomic rearrangement 16 . Accurate identification of chromothripsis requires evidence from both CNAs and SVs. The local SV analysis implemented in CONSERTING runs the SV analysis algorithm CREST 15 at putative CNA segment boundaries using sensitive parameters so that SVs in repetitive regions or SVs with weak signatures (due to, for example, tumor heterogeneity, tumor purity or WGS coverage bias) can be identified without a high genome-wide false positive rate. In the pediatric cancer genomes analyzed in this study, CONSERTING identified 20 CNAs estimated to have 0.25-0.3-fold amplification in SJLGG039, a low-grade glioma tumor with an estimated purity of 30% (ref. 12). Among them, only two CNAs were identified by SNP array (Supplementary Fig. 2f ). Although these CNAs were dispersed, their boundaries were connected through interchromosomal translocations involving seven chromosomes (Fig. 3a) . Twenty percent of the SVs detected by CONSERTING were missed by genome-wide SV analysis as a result of low tumor purity. We designed a three-color fluorescence in situ hybridization assay for one interconnected amplicon involving three CNA segments (Fig. 3b) . On the basis of the SV graph, we expected the three targeted segments to be physically adjacent in red-blue-green order, and indeed, 36% of the 100 nuclei exhibited the red-blue-green fusion signal (Fig. 3c) . Importantly, the SV verified by the red-blue fusion signal produces an in-frame fusion of FYCO1-RAF1, and RAF1 fusions are known driver lesions in low-grade gliomas 12 . Interestingly, various two-color colocalizations such as red-blue and red-green were also noted in a subset of the cells (Fig. 3d) , suggesting that some of the tumor cells might have subsequently undergone additional rearrangement. Subclonal CNAs and SVs resulting from complex rearrangements were also found in retinoblastoma tumor SJRB003. Only a subset of these events were found by standalone CNA or SV analysis because of intratumor heterogeneity ( Supplementary Fig. 5 and Supplementary Data 2).
In the analysis of adult GBM data, CNA and SV profiles computed by CONSERTING showed that double-minute chromosomes generated by complex rearrangments resulted in high-level amplifications of EGFR, MDM2, MDM4, PDGFRA and CDK4 (Supplementary Fig. 6 ). This included three previously reported cases (06-0648-01A, 06-0145-01A and 06-0152-01A) 17 , as well as ten additional cases identified in this study. Nine tumors had a chromothripsis-like CNA-SV profile (Supplementary Fig. 6 ), and two of these (06-0211-01A and 06-0211-02A) had multiple SVs in EGFR, which can result in multiple EGFR isoforms.
The complete genomic landscapes of three samples of acute lymphoblastic leukemia, SJTALL015 (T-ALL), PALETF and PALJDL (B-ALL), have not been reported previously. Therefore, to verify novel CNAs identified by CONSERTING but not by SNP array in gene coding regions for these three tumors, we used custom capture or Sanger sequencing of PCR amplicons encompassing the CNA breakpoints. Ten such CNA segments (range: 10-80 kb) were found, and nine were validated (Supplementary Table 6 and Supplementary Data 3), most notably a 10-kb deletion spanning exons 14-27 of NOTCH1 in SJTALL015 (Supplementary Fig. 7) . CONSERTING predicted an in-frame intragenic deletion of NOTCH1, which was confirmed by Sanger sequencing of both genomic DNA and cDNA. The resulting Using high-coverage WGS data from 43 paired tumor-normal samples, we demonstrated that CONSERTING has much greater sensitivity and accuracy than existing CNA analysis methods and also enhances SV detection by identifying breakpoints with weak SV signatures caused by tumor heterogeneity or low tumor purity. The high concordance of CNAs and SVs detected in the diluted and undiluted samples of adult cancer cell line COLO-829 demonstrates that CONSERTING's increased sensitivity does not come at the cost of an elevated false discovery rate. Tools designed for the characterization of genome deletion polymorphisms in large populations, such as Genome STRiP, also integrate read depth with rearrangement analysis to impove specificity and sensitivity 18 . However, the identification of somatic CNAs is considered a distinct analysis for several reasons: somatic CNAs are occasionally and SKY map data. The one-copy gain of chromosome X was found only in the diluted sample by both CONSERTING and BIC-seq, which is consistent with the SKY data, as there are two copies of chromosome X in this cell line derived from a male patient. npg exceedingly complex (including chromothripsis events), they may exist in a tumor subclone, and recurrence at base-pair resolution across multiple individuals is exceedingly rare.
Although CONSERTING represents a substantial improvement over existing CNA-detection methods, it still has difficulty distinguishing bona fide CNAs from mapping artifacts in regions with high repeat contents such as telomeres and centromeres. In addition, the SV analysis implemented in CONSERTING requires high coverage (>20×) and long WGS reads of ≥75 bp, which may limit its use with existing WGS data sets with shorter read lengths or genomic regions with poor sequence coverage. A subset of WGS data in our study had excessive read-depth changes reminiscent of 'fractured' genomes without matching SVs in the CONSERTING output, and after further analysis we attributed this phenomenon to library-construction artifacts ( Supplementary Fig. 8 and Supplementary Data 4) . Nevertheless, the comprehensive analysis of 43 cancer genomes in this study showed that our method of iterative analysis of read-depth segmentation coupled with SV detection resulted in a significant improvement in CNA detection in WGS data. In addition to the 43 genomes studied here, CONSERTING has been used to carry out CNA analyses for 700 paired tumornormal WGS data sets across 21 subtypes of pediatric cancer generated by the PCGP (Supplementary Fig. 9 ). Recent major findings enabled by CONSERTING included chromothripsisdriven recurrent C11orf95-RELA fusion in supratentorial ependymomas 19 and multiple kinase fusions in pediatric high-grade glioma 20 . These examples demonstrate that high accuracy and sensitivity coupled with base-pair precision enables CONSERTING to make effective use of high-coverage WGS data, which can in turn enhance our understanding of the genetic landscape of cancer genomes. methods Methods and any associated references are available in the online version of the paper.
Accession codes. The diluted COLO-829 cell line, its matching normal cell line and WGS data for SJTALL015 have been deposited at the European Genome-phenome Archive (EGA) under accession EGAS00001001202. Input data for CONSERTING analysis. The input for CONSERTING analysis is BAM files, the compressed binary version of the Sequence Alignment/Map (SAM) format 21 , which store the alignment of WGS reads to the reference human genome. Read depth is summarized from aligned bases with a quality score of ≥15 for each base-pair position of the reference genome using the Coverage module of the program Bambino 22 . A user-defined fixed-size window is used to obtain the mean coverage for each window. The default window size is 100 bp, which was used for all analyses presented here. The mean read depth per window was then normalized to a set of reference diploid chromosomal regions selected on the basis of the following criteria: no loss-ofheterozygosity (LOH) signal within a 1-Mb region, with coverage of the 1-Mb regions within 1.25× the median of all 1-Mb non-LOH regions. Alternatively, reference diploid genomic regions may be provided by the user. The read-depth difference and the log 2 ratio of the tumor and its matching normal were further normalized for GC content by linear regression.
Regression tree segmentation. Regression tree models are popular alternatives to global regression models because they can recursively partition sample spaces into smaller regions using one of the predictor variables until a constant estimate can be fitted for each small region 23 where k is the number of estimated parameters in the tree, which is equal to the number of leaf nodes (constant for each leaf) plus 1 (the constant error variance).
CONSERTING uses an open-source regression tree implementation (the "tree" R package, version 1.0-28 and above). Segment merging. Segment merging is done by (1) pruning the initial tree using the prune.tree function in R, which produces a nested sequence of subtrees of various size and selects the optimal subtree based on BIC criteria (smallest BIC); (2) recursively merging adjacent CNA segments with the most significant t-test P value in each chromosomal region defined by SV breakpoints until all breakpoints reach a genome-wide family-wise error rate of less than 0.05 (the P value is adjusted by Bonferroni correction with the number of tests estimated before the segmentation and remains constant throughout the run); (3) recursively merging adjacent segments with signal differences less than a pre-specified threshold across the whole chromosome (default threshold for difference signal, 0.125; log-ratio signal, 0.170); and (4) calculating a heuristic quality score for each breakpoint using the gap ratio (based on the mapability track in the UCSC genome browser 25 ), segment length, ratio between observed and expected numbers of heterozygous germline SNPs, coverage of neighboring segments in the normal sample, SV support, difference between the read count and difference between the log ratio of the read count at the breakpoint. Breakpoints with quality scores less than a user-specified score are recursively merged.
Local SV detection. Local SV detection uses
Default parameter selections. The default parameters work optimally for next-generation sequencing (NGS) WGS of tumor specimens at 30× coverage, a standard used by the community since the WGS of the first cancer genome 2 . We set the default threshold for signal difference to 0.125, as this allowed us to identify coverage change across a breakpoint with a 0.25 copy gain or loss relative to a normal diploid region, which is a four-read difference in 30× coverage. A lower threshold could be considered for samples with higher coverage.
Running-time analysis. The total running time of CONSERTING comprises three portions: (1) the preprocessing of input datathat is, converting BAMs to BW files using scripts from the UCSC genome browser project and converting BW files to input files for CONSERTING using custom Java code (O(l), where l is the genome length); (2) the read-depth (RD) segmentation (O(iter*nlog(n)), where iter is the number of RD/SV iterations used and n is the number of windows; this step takes ~50 min per iteration on the AWS cloud using 100-bp windows); and (3) the SV detection (O(n 2 ), where n 2 is the number of local SV runs). Running-time analysis using the TCGA-GBM data set without SV parallelization (median running time, 22 CPU-h on an Intel Xeon E5-2670 processor at 2.60 GHz with 128 GB RAM, excluding data preprocessing) showed that the number of local SV detection runs was the significant predictor for running time (P = 1.80 × 10 −9 , R 2 = 0.82). The median memory usage for CONSERTING was 19,352 MB in the TCGA-GBM data set. UCSC's wigToBigWig program uses close to 40 GB of RAM during preprocessing. npg Definition of corroboration. A genomic position is considered to have the corroborated CNA call if its computed CNA type (amplification or deletion) matches the curated CNA from SNP array. A CNA segment computed from one platform is corroborated on another platform if ≥90% of the positions of the segment are corroborated on the other platform. The F 1 score, or the harmonic mean of precision and recall (F 1 2 = × × + (( ) ( )) precision recall precision recall ) between WGS and SNP array, is used to summarize the accuracy for each CNA-analysis method.
Rationale for not using the reciprocal-overlap rule. The reciprocal 50% overlap is a commonly used criterion in comparing CNA calls from different algorithms. However, this criterion might not be appropriate when two CNA calls are derived from platforms with dramatically different powers in detecting focal CNAs. In this study, with a significantly larger average distance between adjacent probes (kilobase pairs in SNP array versus 100 bp in CONSERTING), SNP array-derived CNA calls had an inherently lower resolution than the WGS-based CNA calls, which was proven by the detection of focal events with CONSERTING that were missed by SNP array (Supplementary Table 3) . When a focal CNA occurs on top of a large CNA fragment (such as the homozygous SH2B3 deletion in PALJDL), it breaks the region into multiple segments. Although all WGS CNA fragments in the region corroborated with the SNP array calls, at most one of these fragments satisfied the rule of reciprocal 50% overlap. Consequently, we did not apply the reciprocal 50% overlap in this study.
Preparation and sequencing of diluted COLO-829 DNA. COLO-829 (ATCC CRL-1974) and COLO-829BL (ATCC CRL-1980) were obtained from ATCC (American Type Culture Collection) and separately expanded in culture per ATCC instructions (RPMI-1640 media with 10% FBS at 37 °C, 5% CO 2 ). Cells were not tested for mycoplasma contamination.
Genomic DNA was extracted from both tumor (COLO-829) and normal (COLO-829BL) cells using phenol-chloroform and was treated with RNase A to remove residual RNA. DNA integrity and concentration were assessed by E-Gel agarose gel electrophoresis (Life Technologies) and Qubit dsDNA BR Assay (Life Technologies), respectively. We then created a 50% dilution of the tumor sample by mixing COLO-829 and COLO-829BL genomic DNA in equal concentrations.
WGS libraries of the 50% COLO-829 dilution and the matched normal DNA were constructed using the TruSeq DNA PCR-Free sample preparation kit (Illumina) according to the manufacturer's instructions for 1 µg of genomic DNA input and a 350-bp insert size. Briefly, 1 µg of genomic DNA was sheared by acoustic fragmentation using a Covaris E210 (Covaris). The fragments were end-repaired and then adenylated by the addition of ' A' bases to the 3′ end of the DNA fragments, and an indexing-specific pairedend adaptor was ligated to the fragments. The adaptor-ligated library was then purified using the sample-purification beads provided in the kit.
The resulting WGS libraries were assessed for quality using the Agilent 2200 TapeStation (Agilent Technologies). Library concentrations (nanomolar range) were determined using the Kapa NGS library-quantification kit with Illumina library-specific primers and external standards (Kapa Biosystems) and analyzed on the Eco Real-Time PCR System (Illumina). Libraries were diluted to 2 nM, denatured with sodium hydroxide and clustered on the cBot (Illumina) using the HiSeq PE Cluster Kit v4-cBot Kit (Illumina) according to the manufacturer's instructions. Sequencing was performed on HiSeq 2500 instruments with paired-end (2 × 126 bp) sequencing using Illumina's HiSeq SBS v4 chemistry (Illumina). The 50% COLO-829 dilution was sequenced across three lanes, and the matched normal was sequenced across four lanes. DNA extraction, library preparation and NGS were performed according to standard operating procedures in our CAP/CLIA laboratory.
SKY mapping for COLO-829 can be found at http://www. stjuderesearch.org/site/lab/zhang.
SV support of CNA breakpoints in COLO-829. Validated SVs were downloaded from refs. 14 and 15 and lifted over to hg19. A predicted CNA breakpoint is considered to have SV support if (1) one of the validated SV breakpoints falls within a specified distance (500 bp for CONSERTING, 5 kb for BIC-seq) from the CNA breakpoint, (2) there are no other CNA breakpoints between the SV breakpoint and the CNA breakpoint and (3) the orientation of the SV breakpoint supports the predicted coverage change across the CNA breakpoint.
Paired tumor-normal WGS data. WGS data for the 12 early T cell precursor (ETP)-ALL cases (SJTALL001-009 and 011-013), four retinoblastoma cases (SJRB001-004), B-ALL cases (PALETF and PALJDL) and TCGA GBM data were obtained from dbGaP (http://www.ncbi.nlm.nih.gov/gap) study accessions phs000340. v1.p1, phs000352.v1.p1, phs000218.v1.p1 and phs000178.v8.p7, respectively. The low-grade glioma sample (SJLGG039) is available from the European Genome-phenome Archive under accession EGAS00001000255. TCGA-GBM data downloaded from dbGaP included a total of 46 samples. A subset of the samples (24/46) showed patterns of fractured genome ( Supplementary  Fig. 8 and Supplementary Data 4) and were excluded from WGS-SNP array comparison. WGS data for the diluted COLO-829 cell line and its matching normal cell line have been submitted to the European Genome-phenome Archive under accession EGAS00001001050. WGS data for SJTALL015 have been deposited in EGA under accession EGAS00001001202.
FISH.
Multicolor interphase FISH was performed on formalinfixed paraffin-embedded tissue. Probes were derived from BAC clones (BACPAC Resources, Oakland, CA) and labeled with Alexa Fluor 488, rhodamine or SpectrumAqua fluorochromes. Probes were denatured with target cells at 90 °C for 12 min on a hotplate. The slides were incubated overnight at 37 °C and then washed at 25 °C for 1 min in 4 M urea/2× SSC. Nuclei were counterstained with DAPI (200 ng/ml; Vector Labs).
The following BACs were used to evaluate copy-number abnormalities and any gene fusion: RP11-455K5 located at chr3:12.4 Mb (rhodamine, red), RP11-91P19 and RP11-979G9 located at chr3:46.6 Mb (SpectrumAqua, blue), and RP11-482O1 located at chr11:67.1 Mb (Alexa Fluor 488, green). Table 6 ). PCR reactions were set up with 1 µl DNA template, 0.25 µM forward and reverse primer, 5× Phusion HF buffer, 0.2 mM dNTPs and 0.4 units of Phusion DNA polymerase (New England BioLabs). Reactions were performed on an Eppendorf thermocycler with cycling conditions consisting of a denaturation step at 98 °C for 1 min followed by 33 cycles of (98 °C for 10 s, 66 °C for 15 s, 72 °C for 1 min) and a final extension step at 72 °C for 10 min. PCR products were visualized with GelRed (Biotium) on a 1.5% agarose gel run at 110 V for 1 h, purified using the Wizard PCR purification Kit (Promega), and fusion transcripts were confirmed by direct Sanger sequencing.
Validation of intragenic NOTCH1 deletion by RT-PCR. For amplification of the region spanning the intragenic NOTCH1 deletion, 0.5 µg of total leukemic-cell RNA was reverse-transcribed using the SuperScript III First-Strand kit (Life Technologies). The resulting cDNA was PCR-amplified using AccuPrime polymerase (Life Technologies), and primers were designed within the 500-bp flanking sequences of the boundaries using Primer 3 (ref. 26) (Supplementary Table 6 ). The purified PCR product was subjected to bidirectional Sanger sequencing.
Western blotting of cleaved intracellular NOTCH1. Western blotting for intracellular NOTCH1 (ICN) was done for the T-ALL cell lines MOLT3, HPBALL, DND41, PF382, TALL-1 and LOUCY (Supplementary Fig. 7) . The mouse fibroblast cell line GPE-86 was included as a negative control. Cells were lyzed in RIPA buffer containing protease inhibitors and then underwent proteinconcentration measurement with the BCA Protein Assay Kit (Pierce). Forty micrograms of protein was separated by electrophoresis in NuPAGE 4-12% Bis-Tris gels (Life Technologies) and transferred to nitrocellulose membranes (Whatman). Membranes were probed with an antibody specific for cleaved ICN (2421, Cell Signaling) or α-tubulin (DM1A; 3873, Cell Signaling), followed by staining with secondary HRP-conjugated donkey anti-rabbit (ICN) or donkey anti-mouse (α-tubulin) (Thermo Fisher). After washing, ICN and tubulin proteins were visualized using the Femto Chemiluminescent Kit (Thermo Fisher).
BIC-seq analysis. We used the recommended λ value and a bin size of 100 for all analyses presented in this paper including the paired tumor-normal WGS data. To determine the threshold for amplification and deletion, we first removed the segments that did not reach P ≤ 0.05 after Bonferroni correction. We then tested thresholds between 0.17 and 0.3 for each sample and selected 0.22 for the final report, as it gave the highest F 1 score across all ETP-ALL samples.
SegSeq. To prepare input files for SegSeq, we extracted the chromosomal coordinates (defined as the middle point between the start and end of a read) and orientation of each uniquely mapped read with mapping quality ≥ 35 from the BAM files. SegSeq was run using the default parameters, except that the local window size was set to 300, as this window size showed the highest sensitivity. Only CNAs with copy ratio > 0.2 were retained.
CNV-seq.
We used uniquely mapped reads with mapping quality ≥ 35 as the input to the CNV-seq and first calculated the theoretical minimum window size according to a preset threshold of P < 0.001 and a log 2 copy-number ratio of 0.5 for each pair of tumor and normal samples. For each window, the number of reads was replaced with the mean coverage of the sample if it was less than that number before global normalization and calculations of the log 2 ratio of tumor versus normal and the P value. We then used circular binary segmentation to segment the log 2 ratio values per chromosome and identify candidate gain and loss regions using the following cutoffs: abs(seg.mean) ≥ 0.5, ≥8 markers per segment, and median CNV-seq P values for a segment ≤ 0.001. Finally, we merged the filtered segments where the intersegment distance was less than 500 kb and the copy-number difference was less than 0.25.
CNVnator. A single sample CNV method (CNVnator) was applied independently on the tumor genomes and matching normal genomes of SJTALL002 and SJTALL007. We determined somatic CNAs by subtracting the matching normal genome copy number from the tumor genome copy number. We followed the manual for CNVnator and used a bin size of 100 bp. The optimal threshold for calling CNAs was determined as in BIC-seq analysis, except that we tested a range of (0, 0.5].
